Mycoserology did we move on? Aspergillus;Mykoserologie - sind wir weitergekommen? Aspergillus

Mycoses

Volumn 53, Issue SUPPL. 1, 2010, Pages 26-29

  Kappe, R ^a   Rimek, D ^b  

^a Institut für Laboratoriumsdiagnostik und Mikrobiologie   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Antibody; Aspergillosis; Aspergillus; Galactomannan

Indexed keywords

FUNGUS ANTIGEN; GALACTOMANNAN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ASPERGILLOSIS; ASPERGILLUS; CHRONIC NECROTISING ASPERGILLOSIS; FUNGAL GENE; HUMAN; INVASIVE ASPERGILLOSIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SERODIAGNOSIS; SHORT SURVEY;

ANTIBODIES, FUNGAL; ANTIBODIES, MONOCLONAL; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MANNANS; PRACTICE GUIDELINES AS TOPIC; SEROLOGIC TESTS;

ASPERGILLUS; ASPERGILLUS GALACTOMANNAN; RATTUS;

EID: 77649206207     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2009.01839.x     Document Type: Short Survey

References (9)

1. Maertens J, Theunissen K, Lodewyck T, Lagrou K, Van Eldere J. Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders. Mycoses 2007 50 (Suppl. 1 2 17.
2. Hope WW, Walsh TJ, Denning DW. The invasive and saphrophytic syndromes due to Aspergillus spp. Med Mycol 2005 43 (Suppl. 1 S207 38.
3. Klingspor L, Löffler J. Aspergillus PCR formidable challenges and progress. Med Mycol 2009 47 (Suppl. 1 S241 7.
4. Rimek D, Kappe R. Invasive Aspergillosen: Ergebnisse einer 8-Jahresstudie. Mycoses 2002 45 (Suppl. 3 18 21.
5. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive fungal infections cooperative group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis 2008 46 : 1813 1821.
6. Ruhnke M, Böhme A, Buchheidt D et al. Diagnosis of invasive fungal infections in hematology and oncology. Ann Hematol 2003 82 (Suppl. 2 S141 8.
7. Miceli MH, Grazziutti ML, Woods G et al. Strong correlation between serum Aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin Infect Dis 2008 46 : 1412 1422.
8. Maertens J, Buvé K, Theunissen K et al. Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients. Cancer 2009 115 : 355 362.
9. Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 2008 15 : 1095 1105.